Observed Signal · Oct 20, 2026 · Funding · Source: EU-Startups (European Venture) · Impact: 1/5 · Sentiment: Positive
London's Emerald secures €1.66M for preventive healthcare platform
London-based preventive healthcare platform Emerald has raised an additional €1.66 million (£1.4 million/$1.85 million) in funding, bringing its total to €3.44 million. The round includes an €832.2k grant from Innovate UK and €832.2k in venture capital from new and existing investors, including Sequel and Highgoal. The company plans to use the funds for commercial expansion, product development, and AI enhancements. Since early 2026, Emerald has grown its member base tenfold and processed over 100,000 lab tests, reporting improved health outcomes among users. The startup aims to reach one million members within three years, leveraging partnerships across employee benefits, FinTech, and fitness sectors.
Funding news for a healthcare startup outside the core AdTech/MarTech ecosystem; indirect relevance only.
Track Emerald Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Emerald secured €1.66 million in new funding, bringing total funding to €3.44 million.
- The round includes an €832.2k grant from Innovate UK and €832.2k in venture capital from investors including Sequel and Highgoal.
- Emerald has grown its member base tenfold since early 2026 and processed over 100,000 lab tests.
- The company plans to reach one million members within three years.
- Emerald reported health improvements among users, including lower cholesterol in two out of three members.
Connected Companies & Entities
1 Entity mapped“London-based preventive healthcare platform”
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Healthleap Raises $38M for AI-Powered Hospital Patient Screening
Healthleap, a startup using AI to analyze patient records, has raised $38 million in seed and Series A funding. The round includes an $8 million seed co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures. The platform, deployed in over 50 hospitals, screens patients for conditions like malnutrition and delirium by extracting clinical concepts from clinician notes. Customers include Penn Medicine, Cedars-Sinai, and others. Revenue has grown over 10x in the past year. Funding will support expansion into more health conditions and outpatient care.
Penelope Health Raises €87M for Payer Policy Platform
Penelope Health, a London-based provider of real-time provider and payer policy intelligence, has secured €87 million ($100 million) in funding. The investment was led by healthtech infrastructure platform Thoreau, with participation from existing backers Bertelsmann Healthcare Investments (BHI), Twine Ventures, and Seedcamp. The funding will be used to develop new products aimed at improving administrative efficiency in navigating payer requirements. Penelope's platform converts complex payer policy data into a single infrastructure layer, enabling healthcare companies to check coverage requirements, compare policies, and streamline operations. Currently, it covers policies for over 200 million Americans, spanning more than 15,000 procedures and drug codes. The company also announced a partnership with Thoreau to create a shared layer for real-time payments and clinical rules. This funding round highlights continued investment in European healthcare infrastructure and AI tools aimed at reducing administrative workloads.
Cori Clinical Raises €3.8M to Accelerate Clinical Trials
London-based Cori Clinical, a startup providing an AI-powered intelligence layer for clinical trials, has raised €3.8 million in a Seed round led by Breega, with participation from Enzo, Heartfelt, Together Ventures, and Bynd. The company plans to use the funds to expand delivery capacity, grow its team, and deepen regulatory and clinical intelligence in its platform. Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health. Founded in 2025 by Jorn Jansen Schoonhoven (CEO) and Patricio Fernández (CTO), Cori Clinical creates a 'living blueprint' for trials, integrating internal knowledge with external data from registries and regulatory bodies like FDA, MHRA, and EMA. The startup claims its approach could reduce average trial set-up costs by at least 33%. It already works with two of the top five global CROs and has customers like Erasmus MC.
Receive all future signals for Emerald & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.